Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
14,207,658
-
Share change
-
+2,286,308
-
Total reported value
-
$29,579,615
-
Price per share
-
$2.08
-
Number of holders
-
31
-
Value change
-
+$4,633,211
-
Number of buys
-
22
-
Number of sells
-
11
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q3 2019
As of 30 Sep 2019,
Aptose Biosciences Inc. - Common Shares was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,207,658 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, DRW Securities, LLC, Point72 Asset Management, L.P., Man Group plc, Opaleye Management Inc., P.A.W. CAPITAL CORP, MORGAN STANLEY, SANDERS MORRIS HARRIS LLC, Sigma Planning Corp, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.